Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0277 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_0277 |
| Peptide Name | 125I-β-Amyloid₁₋₄₀ |
| PEPTIDE SEQUENCE (1-letter) | NA |
| PEPTIDE SEQUENCE (3-letter) | NA |
| N-terminal modification | NA |
| C-terminal modification | NA |
| Chemical modification | NA |
| Peptide Length | 40 |
| Conformation | Linear |
| Peptide Nature | NA |
| Source/Origin of peptide | Alzhimer disease Brain |
| SMILES | NA |
| Cell Line | NA |
| In vitro CONCENTRATION | NA |
| In vitro METHOD | Male Sprague-Dawley rats |
| In vitro RESULT | NA |
| ANIMAL MODEL | In conjugation with SA-0X26 vector |
| In vivo CONCENTRATION | NA |
| In vivo MODE OF DELIVERY | Intravenous |
| In vivo METHOD | NA |
| In vivo RESULT | NA |
| ACTION | NA |
| TRANSPORT TYPE | Permeability |
| SUBCELLULAR LOCALISATION | NA |
| COMBINATION | NA |
| PHYSICAL CONDITION | Alzhimer disease Brain |
| RESPONSE | NA |
| RESULT | NA |
| LABEL | NA |
| PMID | 7479757 |